Efficacy and safety of a novel antiviral herbal preparation in ICU-admitted patients with COVID-19: A phase III double-blinded controlled trial

• Hauptverfasser: Hossein Faramarzi (VerfasserIn), Ahmad Hosseinpour (VerfasserIn), Amirhossein Sahebkar (VerfasserIn), Vahid Khaloo (VerfasserIn), Parisa Chamanpara (VerfasserIn), Mohammad Reza Heydari (VerfasserIn), Sajad Najafi (VerfasserIn), Fatemeh Fotoohi Khankahdany (VerfasserIn), Ahmad Movahedpour (VerfasserIn)
• Format: Buch
• Veröffentlicht: Mashhad University of Medical Sciences, 2024-03-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Objective: Despite an increasing number of studies, there is as yet no definite treatment developed for the coronavirus disease 2019 (COVID-19). In this clinical trial, we examined the efficacy of a novel herbal antiviral preparation in critically ill COVID-19 patients.Materials and Methods: A total...